ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,706Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 36

$1.87M Total Retail Price of All Prescriptions

Rank: 2 out of 36

912 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 912 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

7% of this provider’s 912 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 23,478 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 1,029 915 1 4
SIMVASTATIN 960 834 2 1
LEVOTHYROXINE SODIUM 811 752 3 3
LISINOPRIL 807 682 4 2
DONEPEZIL HCL 772 758 5 9
WARFARIN SODIUM 755 620 6 5
METOPROLOL TARTRATE 687 605 7 8
GABAPENTIN 597 457 8 12
TRAZODONE HCL 569 446 9 15
QUETIAPINE FUMARATE 556 530 10 19
OMEPRAZOLE 534 455 11 7
NAMENDA 495 491 12 10
AMLODIPINE BESYLATE 450 429 13 6
ESCITALOPRAM OXALATE 442 404 14 28
METFORMIN HCL 341 266 15 16
IPRATROPIUM-ALBUTEROL 335 311 16 46
FAMOTIDINE 329 260 17 39
SERTRALINE HCL 315 275 18 18
KLOR-CON M20 304 283 19 38
CITALOPRAM HBR 301 236 20 14
HYDROCHLOROTHIAZIDE 297 269 21 13
SEROQUEL 252 235 22 49
TRAMADOL HCL 251 218 23 20
CARVEDILOL 248 213 24 26
CLOPIDOGREL 247 194 25 35
POLYETHYLENE GLYCOL 3350 240 220 26 32
ALENDRONATE SODIUM 234 229 27 36
RISPERIDONE 222 143 28 30
PREDNISONE 207 171 29 31
ALLOPURINOL 207 201 29 34
POTASSIUM CHLORIDE 204 173 31 17
ATORVASTATIN CALCIUM 201 163 32 22
LOSARTAN POTASSIUM 197 154 33 29
CEPHALEXIN 193 176 34 66
LEVETIRACETAM 193 110 34 45
METOPROLOL SUCCINATE 192 166 36 24
ATENOLOL 192 173 36 21
DIVALPROEX SODIUM 190 117 38 59
CYMBALTA 182 127 39 33
ALBUTEROL SULFATE 182 165 39 51
LANTUS 179 143 41 27
HYDROCODONE-ACETAMINOPHEN 175 147 S3 42 11
LOVASTATIN 173 160 43 40
NOVOLOG FLEXPEN 170 118 44 112
TAMSULOSIN HCL 163 121 45 37
NOVOLOG 161 113 46 62
PANTOPRAZOLE SODIUM 155 140 47 48
MIRTAZAPINE 154 138 48 23
PAROXETINE HCL 150 138 49 71
DIOVAN 150 126 49 41
HYDRALAZINE HCL 149 139 51 44
LANTUS SOLOSTAR 149 88 51 98
BUSPIRONE HCL 149 124 51 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 145 127 54 79
NOVOLIN 70-30 140 134 55 126
CLONIDINE HCL 135 121 56 60
LEVOFLOXACIN 132 124 57 92
PLAVIX 131 119 58 58
FLUTICASONE PROPIONATE 123 113 59 53
PRAVASTATIN SODIUM 119 85 60 25
GLIPIZIDE 116 115 61 55
LIDODERM 113 106 62 43
CIPROFLOXACIN HCL 109 96 63 52
SPIRONOLACTONE 107 105 64 76
AGGRENOX 106 94 65 149
ZOLPIDEM TARTRATE 106 93 65 50
LEXAPRO 106 97 65 110
GLUCAGEN 105 65 68 150
NYSTOP 104 93 69 152
BACLOFEN 103 46 70 70
OXYBUTYNIN CHLORIDE ER 96 82 71 75
ISOSORBIDE MONONITRATE ER 94 80 72 42
DIGOXIN 93 85 73 56
METHENAMINE HIPPURATE 91 78 74 157
DOXAZOSIN MESYLATE 90 77 75 103
PROMETHAZINE HCL 89 75 R 76 86
NEXIUM 88 86 77 46
VENLAFAXINE HCL ER 88 63 77 57
VALPROIC ACID 87 46 79 158
AMIODARONE HCL 86 86 80 159
BRIMONIDINE TARTRATE 84 84 81 160
RENVELA 83 60 82 162
NYSTATIN 82 78 83 73
LEVEMIR FLEXPEN 81 77 84 163
ADVAIR DISKUS 80 52 85 54
GLIMEPIRIDE 80 70 85 72
LEVEMIR 77 55 87 115
GLYBURIDE 75 71 R 88 130
DILTIAZEM 24HR CD 75 69 88 82
TIZANIDINE HCL 75 34 88 166
NIFEDIPINE ER 74 60 91 80
TRAVATAN Z 73 73 92 127
LOPERAMIDE 72 61 93 115
PHENYTOIN SODIUM EXTENDED 72 60 93 91
NIASPAN 72 46 93 130
HUMALOG 71 52 96 77
CARBIDOPA-LEVODOPA 69 69 97 64
FINASTERIDE 69 60 97 97
LACTULOSE 67 66 99 93
AZITHROMYCIN 66 55 100 69
KLOR-CON M10 66 55 100 105
ABILIFY 65 65 102 118
AMITRIPTYLINE HCL 65 31 R 102 95
NOVOLIN N 64 39 104 101
CYCLOBENZAPRINE HCL 63 44 R 105 90
MEGESTROL ACETATE 61 58 R 106 180
CHLORHEXIDINE GLUCONATE 61 46 106 123
ONDANSETRON HCL 60 34 108 182
OLANZAPINE 59 55 109 102
AMOXICILLIN 57 46 110 142
FENOFIBRATE 57 25 110 85
CALCITRIOL 54 44 112 190
TERAZOSIN HCL 53 53 113 109
BENAZEPRIL HCL 53 52 113 104
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 52 115 68
DOXYCYCLINE HYCLATE 51 49 116 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.